BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.100
+0.180 (6.16%)
At close: Apr 2, 2025, 4:00 PM
3.035
-0.065 (-2.11%)
After-hours: Apr 2, 2025, 8:00 PM EDT
BioLineRx Stock Forecast
BLRX's stock price has decreased by -90.99% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BioLineRx stock has a target of 26, which predicts an increase of 738.71% from the current stock price of 3.10.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BioLineRx stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $26 | Strong Buy | Maintains | $9 → $26 | +738.71% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $840 → $360 | Strong Buy | Maintains | $840 → $360 | +11,512.90% | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $840 | Strong Buy | Reiterates | $840 | +26,996.77% | Nov 6, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +2,480.65% | Sep 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.